NCT06342492 Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure
| NCT ID | NCT06342492 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kansas City Heart Rhythm Research Foundation |
| Condition | Heart Failure With Reduced Ejection Fraction |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-11-07 |
| Primary Completion | 2024-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-11-07 with a primary completion date of 2024-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This a single-center, retrospective, observational study of patients that undergo coronary sinus(CS) lead revision, comparing epicardial lead placement to coronary sinus pacing(CSP) in those that had lead failure.
Eligibility Criteria
Inclusion Criteria: * All patients older than 18 years of age * Patients with HFrEF that underwent BVP-CRT * Experienced CS lead failure, whether initial or recurrent, subsequently replaced with transthoracic epicardial lead placement or CSP * Underwent Medtronic, Boston Scientific, or Abbott lead placement Exclusion Criteria: * Patients younger than 18 years of age * Transthoracic epicardial lead placement or CSP performed as the initial approach or for other reasons than lead replacement * Those for which CRT no longer provides symptom relief or mortality benefit.
Contact & Investigator
Naga Venkata K. Pothineni
PRINCIPAL INVESTIGATOR
Kansas City Heart Rhythm Institute
Frequently Asked Questions
Who can join the NCT06342492 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure With Reduced Ejection Fraction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06342492 currently recruiting?
Yes, NCT06342492 is actively recruiting participants. Contact the research team at datkins@kchrf.com for enrollment information.
Where is the NCT06342492 trial being conducted?
This trial is being conducted at Overland Park, United States.
Who is sponsoring the NCT06342492 clinical trial?
NCT06342492 is sponsored by Kansas City Heart Rhythm Research Foundation. The principal investigator is Naga Venkata K. Pothineni at Kansas City Heart Rhythm Institute. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.